Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2008

Feb 8, 2008

29777_dirs_2008-02-07_a252ec70-81de-4dd1-8f09-42083ddb5e68.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-02-05

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-02-05 Common shares without par value M 2012 $54.62 Acquired 297347 Direct
2008-02-05 Common shares without par value F 1936 $58.05 Disposed 295411 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-02-05 Common shares without par value $54.62 M 2012 Disposed 2008-02-12 Common shares (2012) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 19894 Indirect
Common shares without par value 845 Indirect
Common shares without par value 845 Indirect
Common shares without par value 845 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 5, 2008

F2: Reporting person disclaims beneficial ownership of all securities held by his daughter and sons.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.